Saiakuntzen zerrenda

Ikerketa


Saiakuntzaren kategoriak

Choroideremia Gene Therapy Clinical Trial

Estado: | Categoría: | Resultado:

Patología

coroideremia

Tratamiento

BiologiCO: Injecci n de AAV2-REP1 (10e11 vg)

Localizaciones

Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
Ver informe

Trial of Oral Valproic Acid for RETINOSIS Pigmentosa

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARFIA

Tratamiento

Drug: Valproic Acid Drug: Placebo

Localizaciones

University of Miami, Bascom Palmer Eye Institute, Miami, Florida, United States University of Michigan, Ann Arbor, Ann Arbor, Michigan, United States Oregon Health & Science University, Portland, Oregon, United States University of Tennessee, Hamilton Eye Institute, Memphis, Tennessee, United States Retina Foundation of the Southwest, Dallas, Texas, United States University of Utah School of Medicine, Moran Eye Center, Salt Lake City, Utah, United States
Ver informe

DHA and X-Linked Retinitis Pigmentosa

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA ENFERMEDAD GENETICA LIGADA A X

Tratamiento

Drug: docosahexaenoic acid OR corn/soy oil placebo

Localizaciones

Retina Foundation of the Southwest, Dallas, Texas, United States
Ver informe

Efficacy of Acupuncture in Macular Diseases

Estado: | Categoría: | Resultado:

Patología

DEGENERACION MACULAR ASOCIAQDA A LA EDAD ENFERMEDAD DE STARGARDT DISTROFIA MACULAR

Tratamiento

Other: Acupuncture and massage

Localizaciones

IPS Fundaci n Neijing, Guarne, Antioquia, Colombia IPS Fundaci n Neijing, Medellin, Antioquia, Colombia
Ver informe

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Localizaciones

Greater Baltimore Medical Center, Baltimore, Maryland, United States Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States Retina Foundation of the Southwest, Dallas, Texas, United States Moran Eye Center, University of Utah, Salt Lake City, Utah, United States Institut de la Vision, Paris, France Center for Ophthalmic Research, University of Teubingen, T bingen, Germany Moorfields Eye Hospital, London, United Kingdom
Ver informe

Phase I/IIA Study of SAR422459 in Participants With Stargardt’s Macular Degeneration

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT

Tratamiento

MEDICAMENTO: SAR422459

Localizaciones

Investigational Site Number 840002, Miami, Florida, United States Investigational Site Number 840005, Iowa City, Iowa, United States Investigational Site Number 840001, Portland, Oregon, United States Investigational Site Number 840004, Houston, Texas, United States Investigational Site Number 250001, Paris, France
Ver informe

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to ENFERMEDAD DE STARGARDT

Estado: | Categoría: | Resultado:

Patología

ENFERMEDAD DE STARGARDT Macular Atrophy

Tratamiento

MEDICAMENTO: Emixustat

Localizaciones

Dallas, Texas, United States
Ver informe

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

Estado: | Categoría: | Resultado:

Patología

Inherited Retinal Dystrophy Due to RPE65 Mutations Leber Congenital Amaurosis

Tratamiento

Biological: AAV2-hRPE65v2,voretigene neparvovec-rzyl

Localizaciones

University of Iowa, Iowa City, Iowa, United States Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Ver informe

RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa

Estado: | Categoría: | Resultado:

Patología

Advanced RETINOSIS PIGMENTARIA

Tratamiento

Drug: RST-001

Localizaciones

University of California, San Francisco- Dept. of Ophthalmology, San Francisco, California, United States Duke Eye Center, Durham, North Carolina, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Retina Foundation of the Southwest, Dallas, Texas, United States
Ver informe

Feasibility Study of a Chronic Retinal Stimulator in RETINOSIS PIGMENTARIA

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Device: Argus 16 Retinal Stimulation System

Localizaciones

Doheny Eye Institute, Los Angeles, California, United States
Ver informe